Related Experiment Videos
Conceptualization vs reality in periodontal therapy: genetic testing and host modulation
1Department of Periodontology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA.
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)
|June 7, 2003
Summary
This study examines the reliability of genetic susceptibility tests for periodontitis and the use of subantimicrobial-dose doxycycline in treating periodontal disease. It assesses their practical application in managing chronic periodontitis patients.
Area of Science:
- Periodontology
- Genetics
- Pharmacology
Background:
- Chronic periodontitis poses a significant global health challenge.
- Genetic predisposition and pharmacological interventions are key areas in periodontitis management.
- Controversies exist regarding the clinical utility of genetic susceptibility testing and subantimicrobial-dose doxycycline.
Purpose of the Study:
- To critically evaluate the reliability of genetic susceptibility tests for identifying individuals at risk of periodontitis.
- To assess the efficacy and practical application of subantimicrobial-dose doxycycline in treating periodontal diseases.
- To discuss the implications of these tools in the clinical management of chronic periodontitis.
Main Methods:
- Literature review and critical analysis of existing studies on genetic testing for periodontitis.
- Systematic review of clinical trials investigating subantimicrobial-dose doxycycline for periodontal treatment.
- Assessment of evidence regarding the predictive value and clinical utility of genetic tests.
- Evaluation of the therapeutic benefits and drawbacks of subantimicrobial-dose doxycycline.
Main Results:
- The reliability and clinical utility of genetic susceptibility tests for periodontitis remain controversial, with limited evidence supporting their routine use.
- Subantimicrobial-dose doxycycline shows potential benefits in managing periodontal diseases, particularly in reducing inflammation and probing depths, but its long-term efficacy and optimal use require further investigation.
- Both approaches present challenges in practical application within routine patient management.
Conclusions:
- Current genetic susceptibility tests lack sufficient validation for widespread clinical adoption in periodontitis risk assessment.
- Subantimicrobial-dose doxycycline offers a viable adjunctive therapy for periodontal disease, warranting careful consideration in treatment planning.
- Further research is needed to clarify the roles of genetic testing and subantimicrobial-dose doxycycline in personalized periodontitis management.